Ascendis Pharma A (ASND) Change in Receivables (2014 - 2026)
Ascendis Pharma A (ASND) reported Change in Receivables of -$28.68 million for the quarter ended Jun 30, 2026, compared with -$54.32 million a year earlier.
Powered by 
Analysis
Ascendis Pharma A (ASND) Change in Receivables (2014 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Ascendis Pharma A's Change in Receivables came in at $6.06 million; for the year ended Dec 31, 2025, it came in at $131.72 million.
- By year, Change in Receivables came in at -$128.37 million in the year ended Dec 31, 2024, -$35.45 million in the year ended Dec 31, 2023, -$12.15 million in the year ended Dec 31, 2022 and -$7.62 million in the year ended Dec 31, 2021.
- Five-year quarterly Change in Receivables spans a low of -$133.36 million in the quarter ended Dec 31, 2024 and a high of $106.45 million in the quarter ended Dec 31, 2025.
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at -$42.59 million (quarter ended Mar 31, 2026), $106.45 million (quarter ended Dec 31, 2025) and -$29.12 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 1.35 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 1.37 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 1.09 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 333.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | Ascendis Pharma A | 14.48 Bn | 10.74 Bn | 362.22 Mn | 113.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 113.25 Mn |
| Mar 31, 2026 | -42.59 Mn |
| Dec 31, 2025 | 11.12 Mn |
| Sep 30, 2025 | 29.12 Mn |
| Jun 30, 2025 | 54.32 Mn |
| Mar 31, 2025 | -103.12 Mn |
| Dec 31, 2024 | 133.36 Mn |
| Sep 30, 2024 | -31.78 Mn |
| Jun 30, 2024 | 12.34 Mn |
| Mar 31, 2024 | 12.26 Mn |
| Dec 31, 2023 | 9.17 Mn |
| Sep 30, 2023 | 14.73 Mn |
| Jun 30, 2023 | 1.21 Mn |
| Mar 31, 2023 | 10.31 Mn |
| Dec 31, 2022 | 5.57 Mn |
| Sep 30, 2022 | 379,111.15 |
| Jun 30, 2022 | 3.51 Mn |
| Mar 31, 2022 | 2.70 Mn |
| Dec 31, 2021 | -3.02 Mn |
| Sep 30, 2021 | 6.20 Mn |
API Access
Ascendis Pharma A Change in Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-receivables&ticker=ASND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-receivables", "ticker": "ASND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-receivables&ticker=ASND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();